(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMA DE DOSAGEM ORAL SÓLIDA COMPREENDENDO POMALIDOMIDA.

Em ExigênciaInvention PatentPCT · IB2021053073

Application data

Number

112022020897

Type

Invention Patent

Filing

04/14/2021

Publication

11/29/2022

PCT

IB2021053073

Progress at the INPI

Technical opinion to answer
  1. Filing04/14/21
  2. Publication11/29/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/10/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TECNIMEDE, SOCIEDADE TÉCNICO-MEDICINAL, SA

PT

Inventors

J. F. (pessoa física)

PT

J. S. (pessoa física)

PT

Technical data

Priority claims

EP

20169699.4 · 04/15/2020

PT

116261 · 04/15/2020

Abstract

FORMA DE DOSAGEM ORAL SÓLIDA COMPREENDENDO POMALIDOMIDA. A presente divulgação refere-se à formulação de novas formas de dosagem farmacêuticas da pomalidomida para uso terapêutico. As novas formas de dosagem farmacêuticas são uma composição farmacêutica de liberação imediata compreendendo pomalidomida.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

06/10/2025

RPI 2840

Notificação de entrada na fase nacional - PCT

#1.3

11/29/2022

RPI 2708

Alteração de dados cadastrais

#1.1

10/25/2022

RPI 2703

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.